Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma
2023Journal of Genetic Engineering and BiotechnologyJournalOpen access
10.1186/s43141-023-00577-8Full text2 citations